Literature DB >> 23329641

Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.

Cristina Eguizabal1, Nuria Montserrat, Anna Veiga, Juan Carlos Izpisua Belmonte.   

Abstract

The main goal of regenerative medicine is to replace damaged tissue. To do this it is necessary to understand in detail the whole regeneration process including differentiated cells that can be converted into progenitor cells (dedifferentiation), cells that can switch into another cell type (transdifferentiation), and somatic cells that can be induced to become pluripotent cells (reprogramming). By studying the regenerative processes in both nonmammal and mammal models, natural or artificial processes could underscore the molecular and cellular mechanisms behind these phenomena and be used to create future regenerative strategies for humans. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23329641     DOI: 10.1055/s-0032-1331802

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  21 in total

Review 1.  Dedifferentiated fat cells: A cell source for regenerative medicine.

Authors:  Medet Jumabay; Kristina I Boström
Journal:  World J Stem Cells       Date:  2015-11-26       Impact factor: 5.326

Review 2.  Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang
Journal:  NPJ Regen Med       Date:  2020-07-31

Review 3.  miRNA control of tissue repair and regeneration.

Authors:  Chandan K Sen; Subhadip Ghatak
Journal:  Am J Pathol       Date:  2015-06-06       Impact factor: 4.307

Review 4.  Transflammation: Innate immune signaling in nuclear reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Adv Drug Deliv Rev       Date:  2017-09-13       Impact factor: 15.470

Review 5.  Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Antioxid Redox Signal       Date:  2018-04-26       Impact factor: 8.401

Review 6.  Reprogramming by lineage specifiers: blurring the lines between pluripotency and differentiation.

Authors:  Ignacio Sancho-Martinez; Alejandro Ocampo; Juan Carlos Izpisua Belmonte
Journal:  Curr Opin Genet Dev       Date:  2014-10-14       Impact factor: 5.578

Review 7.  Mechanisms of Lung Fibrosis Resolution.

Authors:  Stephan W Glasser; James S Hagood; Simon Wong; Carmen A Taype; Satish K Madala; William D Hardie
Journal:  Am J Pathol       Date:  2016-03-25       Impact factor: 4.307

8.  In vivo dedifferentiation of adult adipose cells.

Authors:  Yunjun Liao; Zhaowei Zeng; Feng Lu; Ziqing Dong; Qiang Chang; Jianhua Gao
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

9.  Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes.

Authors:  R Piran; S-H Lee; C-R Li; A Charbono; L M Bradley; F Levine
Journal:  Cell Death Dis       Date:  2014-07-31       Impact factor: 8.469

Review 10.  Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective.

Authors:  Cristina Eguizabal; Olatz Zenarruzabeitia; Jorge Monge; Silvia Santos; Miguel Angel Vesga; Natalia Maruri; Arantza Arrieta; Marta Riñón; Estibaliz Tamayo-Orbegozo; Laura Amo; Susana Larrucea; Francisco Borrego
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.